Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Alterations in DNA methylation associate with reduced migraine and headache days after medication withdrawal treatment in chronic migraine patients: a longitudinal study

Fig. 2

Manhattan plot from the epigenome‐wide association study. Manhattan plot showing the –log10(p value) for each CpG site associated with changes in DNA methylation in monthly headache days (MHD) responders versus non-responders. The threshold for epigenome-wide significant association (p < 9.42 × 10–8) is indicated by a solid black line. The threshold for epigenome-wide suggestive association (p < 5 × 10–5) is indicated by a dashed black line

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us